share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

SEC announcement ·  Mar 13 08:49
Summary by Futu AI
John Trizzino, President and COO of Novavax Inc, completed a stock transaction on March 10, 2024. The transaction involved the sale of 2,226 shares of Novavax common stock at a price of $5.45 per share, resulting in a total market value of $12,131.70. Prior to this sale, Trizzino exercised options to acquire 4,608 shares of the company's stock. Following these transactions, Trizzino's direct holdings in Novavax amounted to 27,972 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
John Trizzino, President and COO of Novavax Inc, completed a stock transaction on March 10, 2024. The transaction involved the sale of 2,226 shares of Novavax common stock at a price of $5.45 per share, resulting in a total market value of $12,131.70. Prior to this sale, Trizzino exercised options to acquire 4,608 shares of the company's stock. Following these transactions, Trizzino's direct holdings in Novavax amounted to 27,972 shares. The sale was conducted under a transaction code indicating the payment of exercise price or tax liability by delivering or withholding securities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.